Teneligliptin Placebo Oral Tablet

DRUG2 trials

Sponsors

Handok Inc.

Conditions

Type 2 Diabetes

Phase 3

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

CompletedNCT05504226

Handok Inc.Type 2 Diabetes

Start: 2022-10-12End: 2024-06-18Updated: 2025-01-27

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin

CompletedNCT05504239

Handok Inc.Type 2 Diabetes

Start: 2022-09-27End: 2024-04-23Updated: 2025-01-24